MicroRNAs, transforming growth factor beta-1, and tissue fibrosis.
about
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic DiseasesMicroRNAs in Diabetic Nephropathy: From Biomarkers to TherapyRegulation of synthesis and roles of hyaluronan in peritoneal dialysisSystemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated MiceDysregulated miR-27a-3p promotes nasopharyngeal carcinoma cell proliferation and migration by targeting Mapk10.Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis.MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis.Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy.MicroRNA MiR-199a-5p regulates smooth muscle cell proliferation and morphology by targeting WNT2 signaling pathway.Pathophysiological role of microRNA-29 in pancreatic cancer stromaMiRNA inhibition in tissue engineering and regenerative medicine.Tissue Transglutaminase-Regulated Transformed Growth Factor-β1 in the Parasite Links Schistosoma japonicum Infection with Liver Fibrosis.MicroRNA Expression Profiling in CCl₄-Induced Liver Fibrosis of Mus musculus.Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.Characterization of miRNA-regulated networks, hubs of signaling, and biomarkers in obstruction-induced bladder dysfunctionThe role of microRNAs in skin fibrosis.Inflammation, wound repair, and fibrosis: reassessing the spectrum of tissue injury and resolutionMolecular basis of organ fibrosis: potential therapeutic approaches.Epigenetics in immune-mediated pulmonary diseases.Transforming growth factor-beta 1 pathways in inflammatory airway diseases.Illustrating the interplay between the extracellular matrix and microRNAs.Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development.Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosisEpigenetics in radiation-induced fibrosis.Acute kidney injury: a paradigm for miRNA regulation of the cell cycle.Tissue engineering and microRNAs: future perspectives in regenerative medicine.MicroRNA-29: A Crucial Player in Fibrotic Disease.microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.Understanding the process of fibrosis in Duchenne muscular dystrophy.MiR-199a-3p suppresses proliferation and invasion of prostate cancer cells by targeting Smad1.Regulation of tissue fibrosis by the biomechanical environment.Endoplasmic reticulum stress enhances fibrosis through IRE1α-mediated degradation of miR-150 and XBP-1 splicing.Reovirus type-2-triggered autoimmune cholangitis in extrahepatic bile ducts of weanling DBA/1J mice.microRNA profiles in coeliac patients distinguish different clinical phenotypes and are modulated by gliadin peptides in primary duodenal fibroblasts.MiR-5100 targets TOB2 to drive epithelial-mesenchymal transition associated with activating smad2/3 in lung epithelial cells.Transforming Growth Factor-β and Bone Morphogenetic Protein 2 Regulation of MicroRNA-200 Family in Chronic Pancreatitis.MicroRNA-21 preserves the fibrotic mechanical memory of mesenchymal stem cells.Exosomes from patients with septic shock convey miRNAs related to inflammation and cell cycle regulation: new signaling pathways in sepsis?Human Fibrotic Diseases: Current Challenges in Fibrosis Research.Stabilization of Urinary MicroRNAs by Association with Exosomes and Argonaute 2 Protein.
P2860
Q26748338-F898E39A-0D67-4C19-A421-975970CD0ED0Q26766102-73C1A9D3-8150-42AA-978E-36D9240E3F50Q26778414-B1A43F86-A21F-48A9-9BA1-579F05463156Q28546811-A374C1E6-68CC-42D4-A5C0-0D694553F5F7Q33671062-48CB4218-487C-4B12-961D-DA67AEB1C9E5Q33720132-D26A179F-A5B3-483B-BD5B-2599D01875A1Q33731819-7ADCA16A-14E1-4316-8153-5BA60704AA1AQ34332718-7F909B49-B39D-45FB-B975-CE08256050D1Q35172664-FC4E3263-BC84-4E1D-81F3-1B47D0273BE1Q35765000-DDB27A36-FB50-4C5C-9C4B-571C356FC16CQ35799937-7656900B-EF32-484A-98D9-0B2AD5FB6D41Q35823916-BA641532-5608-4800-B387-73852898D622Q37050843-904C9C5C-8C8F-4072-9829-0F04FBAC806FQ37224668-25A305F9-1AB9-47B3-B032-1F7F65559E53Q37599555-4E23F88D-D7F3-4E8B-B129-E3A51D2EDCF3Q37691772-04587F56-3F83-4234-9956-99C7DD13AD00Q38055448-0B9FAC64-D065-4A10-8CCF-769E544BE54CQ38121751-C017D511-DC91-47E3-9545-D3A911DC2EA5Q38163413-7E6295AA-5862-428A-B9A9-F45DF33ECDB1Q38205902-0F27BB85-2DAF-4358-A36D-46AE9D02EC23Q38206794-345D2E4D-6C73-489C-84AC-A6CFE57BEA2DQ38206962-65F81189-7375-4174-8009-78904B817E77Q38213707-105537D0-FFAB-493F-9B1E-1650D890335FQ38218535-B5F316EA-8BBE-4DB0-A600-A0EDF3A8821DQ38238683-09A1B476-1077-4510-8647-93C66222E10BQ38552026-577A9DC1-FAA1-4A58-9AD9-54F5F11FE56AQ39107249-355F057A-73E7-4A04-B326-6246E7F2CDB1Q39137248-FBDD4AE8-7BB6-4318-82FC-D3183FAED0D4Q39699112-19EA7350-2707-49A6-B6AC-175433DCCABCQ41592757-30FFF542-0D3A-404D-B70A-B389BA7436E8Q41775151-F7883373-E3A6-48D0-8084-35740D01F1CFQ41811106-BEFF4641-9DCF-4952-B408-677E98C1792BQ42262795-EEF4BAF8-D565-4557-8496-398A0C8ADD79Q44236750-B6A30744-D816-45D5-BCA7-D4E0C14DC1B7Q44528775-B0E27311-A6CC-4C6E-94AA-2B5E51D37168Q47230168-94D3B4E8-2D0F-4672-9A62-6DAC501E918DQ48260543-8789F637-46E8-43CA-9701-990EAB7A5751Q51733913-AB177898-9D33-4A0B-8A5B-0EE8B59B0A8DQ52536468-33376246-290B-4C2F-AF4A-27655D8349ADQ55065698-ECCDF9C9-3DF1-4C5D-A0DA-0D86B3FEC91D
P2860
MicroRNAs, transforming growth factor beta-1, and tissue fibrosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
MicroRNAs, transforming growth factor beta-1, and tissue fibrosis.
@en
type
label
MicroRNAs, transforming growth factor beta-1, and tissue fibrosis.
@en
prefLabel
MicroRNAs, transforming growth factor beta-1, and tissue fibrosis.
@en
P2860
P356
P1476
MicroRNAs, transforming growth factor beta-1, and tissue fibrosis
@en
P2093
Timothy Bowen
P2860
P304
P356
10.1002/PATH.4119
P577
2012-11-29T00:00:00Z